Abstract
The life sciences (LS) sector is one of the most innovative and technology-driven industries (Mroczkowski 2012). Consequently, many LS ventures face a high-tech market characterized by a high level of market uncertainty and disruptive innovations. In addition, the life sciences sector is strongly intertwined with regulatory bodies and international agencies, which again tend to increase the level of uncertainty and complexity of the market and the business models applied (Seifert et al. 2008; Jones et al. 2011). Obviously, the complexity of the LS sector also influences typical marketing and sales activities needed to commercialize new products or services and further nurture the venture. The objectives of this paper are to introduce the major challenges for LS ventures in the field of marketing and sales and indicate how best to approach and optimize the commercialization performance of LS ventures.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Altug, M. (2016). Supply chain contracting for vertically differentiated products. International Journal of Production Economics, 171(1), 34–45.
Attia, A., Honeycutt, E., & Leach, M. (2005). A three-stage model for assessing and improving sales force training and development. Journal of Personal Selling & Sales Management, 25(3), 253–268.
Ding, M., Eliashberg, J., & Stremersch, S. (2014). Innovation and Marketing in the Pharmaceutical Industry. New York: Springer.
Hill, G., & Hill, K. (1995). Real life dictionary of the law: Taking the mystery out of the legal language. Los Angeles: General Publishing Group.
Hinterhuber, A. (2003). Towards value-based pricing – An integrative framework for decision making. Industrial Marketing Management, 33, 765–778.
Hinterhuber, A., & Bertini, M. (2011). Profiting when customers choose value over price. Business Strategy Review, 22(1), 46–49.
Jones, M., Wheeler, C., & Dimitratos, P. (2011). International entrepreneurship in life sciences. Cheltenham: Edward Elgar.
Krütten, J., Rautenberg, F., & Liefner, M. (2005). Zukünftige Relevanz und Konsequenzen von Krankenhauseinkaufskooperationen für Medizintechnologie-Anbieter in Deutschland. Bonn: Simon-Kucher & Partners.
Laurell, H., Andersson, S., & Achtenhagen, L. (2013). The importance of industry context for new venture internalization: A case study from the life sciences. New York: Springer.
Mohr, J., Sengupta, S., & Slater, S. (2010). Marketing of high-technology products and innovations (3. Aufl.). Upper Sadle River: Prentice Hall.
Mroczkowski, T. (2012). The new players in life science innovation: best practices in R&D from around the world. Upper Saddle River: FT Press.
Onetti, A., & Zucchella, A. (2014). Business modeling for life science and biotech companies. New York: Routledge.
Petrova, E. (2014). Innovation in the pharmaceutical industry: The process of drug discovery and development. In M. Ding, J. Eliashberg, & S. Stremersch (Hrsg.), Innovation and marketing in the pharmaceutical industry (S. 19–81). New York: Springer.
Seifert, R., Leleux, B., & Tucci, C. (2008). Nurturing science-based ventures. London: Springer.
Stremersch, S., & Van Dyck, W. (2009). Marketing of life sciences: A new framework and research agenda for a nascent field. Journal of Marketing, 73, 4–30.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Fachmedien Wiesbaden GmbH
About this chapter
Cite this chapter
Keller, M., Schnell, G. (2017). Marketing and Sales for LS Ventures. In: Becker, J., Villinger, T. (eds) Life Science Venturing. Springer Gabler, Wiesbaden. https://doi.org/10.1007/978-3-658-06382-5_6
Download citation
DOI: https://doi.org/10.1007/978-3-658-06382-5_6
Published:
Publisher Name: Springer Gabler, Wiesbaden
Print ISBN: 978-3-658-06381-8
Online ISBN: 978-3-658-06382-5
eBook Packages: Business and Economics (German Language)